Filing Details

Accession Number:
0001722482-22-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-05 16:59:24
Reporting Period:
2022-01-02
Accepted Time:
2022-01-05 16:59:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1722482 Avantor Inc. AVTR Laboratory Analytical Instruments (3826) 822758923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1776107 Gerard Brophy Radnor Corporate Center, Building One,
Suite 200, 100 Matsonford Road
Radnor PA 19087
Evp, Biopharma Production No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-01-02 6,516 $42.14 142,863 No 4 F Direct
Common Stock Acquisiton 2022-01-03 59,418 $18.45 202,281 No 4 M Direct
Common Stock Disposition 2022-01-03 59,418 $40.77 142,863 No 4 S Direct
Common Stock Disposition 2022-01-05 11,551 $38.65 131,312 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2022-01-03 59,418 $0.00 59,418 $18.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
59,417 2030-01-02 No 4 M Direct
Footnotes
  1. Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
  2. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $40.27 to $41.97, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $38.44 to $38.87, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth above.
  5. Reflects an initial grant of 178,253 stock options that vest in three equal installments beginning on January 2, 2021.